Connor Clark & Lunn Investment Management Ltd. raised its position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 171.3% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 394,019 shares of the company's stock after acquiring an additional 248,762 shares during the quarter. Connor Clark & Lunn Investment Management Ltd. owned approximately 0.23% of Option Care Health worth $9,141,000 at the end of the most recent quarter.
Other institutional investors have also recently made changes to their positions in the company. HighTower Advisors LLC grew its stake in Option Care Health by 16.7% in the fourth quarter. HighTower Advisors LLC now owns 468,082 shares of the company's stock worth $10,860,000 after purchasing an additional 67,021 shares during the period. AlphaQuest LLC grew its position in shares of Option Care Health by 417.8% in the 4th quarter. AlphaQuest LLC now owns 23,520 shares of the company's stock worth $546,000 after buying an additional 18,978 shares during the period. PNC Financial Services Group Inc. increased its stake in shares of Option Care Health by 5.5% in the 4th quarter. PNC Financial Services Group Inc. now owns 28,840 shares of the company's stock worth $669,000 after acquiring an additional 1,509 shares in the last quarter. Global Alpha Capital Management Ltd. lifted its position in Option Care Health by 38.1% during the 4th quarter. Global Alpha Capital Management Ltd. now owns 68,810 shares of the company's stock valued at $1,596,000 after acquiring an additional 18,992 shares during the period. Finally, Edgestream Partners L.P. purchased a new position in shares of Option Care Health during the fourth quarter valued at approximately $6,932,000. Institutional investors own 98.05% of the company's stock.
Option Care Health Stock Performance
Option Care Health stock traded up $0.19 during trading on Wednesday, reaching $34.52. The company had a trading volume of 1,136,498 shares, compared to its average volume of 1,623,294. The firm has a market capitalization of $5.71 billion, a price-to-earnings ratio of 29.01, a price-to-earnings-growth ratio of 2.30 and a beta of 1.33. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The firm's 50-day simple moving average is $31.22 and its 200 day simple moving average is $28.25. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $34.85.
Analysts Set New Price Targets
A number of equities analysts recently issued reports on the stock. JMP Securities reiterated a "market outperform" rating and issued a $30.00 price target (down previously from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. UBS Group initiated coverage on Option Care Health in a research report on Thursday, December 5th. They issued a "neutral" rating and a $26.00 price objective on the stock. JPMorgan Chase & Co. lifted their target price on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a report on Thursday, March 6th. Jefferies Financial Group raised Option Care Health from a "hold" rating to a "buy" rating and upped their price target for the company from $26.00 to $35.00 in a report on Thursday, January 23rd. Finally, Bank of America raised shares of Option Care Health from a "neutral" rating to a "buy" rating and lifted their target price for the stock from $26.00 to $33.00 in a research report on Monday, January 13th. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $33.00.
Check Out Our Latest Stock Report on Option Care Health
Insider Transactions at Option Care Health
In related news, insider Michael Bavaro sold 30,996 shares of the stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the sale, the insider now directly owns 44,974 shares of the company's stock, valued at approximately $1,495,835.24. This represents a 40.80 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 0.64% of the company's stock.
Option Care Health Profile
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Read More
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
